Dr. Pace has over thirty years of experience in the life science field, with 20 years legal and corporate experience and 12 years in biotech research for large and small companies.   He is a registered patent attorney with a record of over 40 issued US patents.  Since 2001 he has helped many early and development stage companies in the life sciences with their strategic, intellectual property, and transactional activities.  Dr. Pace has held executive management positions in several companies, including Novartis Corporation, Gentris Corporation, Quill Medical, Inc., and BASF Corporation.  Dr. Pace has a J.D. degree from the School of Law at North Carolina Central University, and his Ph.D. from North Carolina State University.

Dr. Hartman has over 15 years of research and development experience in a range of disciplines, including oncology, stem cell biology, toxicology, and regenerative medicine in both academic and industry settings. She is focused on identifying and developing novel product applications for cellular and genomics workflows for the CellRaft Technology. She most recently served as the Director of Cell-Based Assay Development at ScitoVation. Dr. Hartman received a Ph.D. in Molecular Cancer Biology from Duke University and holds a Bachelor of Science degree in Biology from the University of Virginia.

Dr. Gebhart has over ten years of research and development experience in medical and life science product development, with an emphasis in optical imaging, spectroscopy, and interferometry. He most recently served as Manager of Product Development and Manufacturing at Oncoscope, Inc. where he served as principal investigator on multiple NIH and NSF Phase I, II, and IIB SBIR grant awards. Dr. Gebhart has a Ph.D. degree in biomedical engineering from Vanderbilt University, where he completed his doctoral work in the biomedical optics laboratory of Anita Mahadevan-Jansen, Ph.D. He also holds a Bachelor of Science degree from Duke University in biomedical engineering.

Mr. Kane is responsible for the sales and sales operations efforts at Cell Microsystems, with an emphasis on growing commercial focus. He brings a breadth of biotechnology industry experience in both scientific and sales roles focusing on molecular biology, laboratory instrumentation, and genomics. Previously, he served in senior sales roles at BD Genomics, Fluidigm, Pacific Biosciences, and QIAGEN. Mr. Kane has a Bachelor of Science in Biology from Virginia Tech and a Master of Business Administration from Julius-Maximilians-Universität Würzburg.

Mr. McClellan leads Cell Microsystems’ efforts in software systems engineering for automated platforms that incorporate the CellRaft Technology.  Mr. McClellan’s professional experience covers 30 years in automation, image processing, software engineering, and research & development.  After beginning his career conducting medical imaging research at Cornell University, he developed products in the high speed paper handling industry at Pitney Bowes, General Binding and Bell + Howell.  Most recently, he worked for Monsanto Company developing imaging applications for agricultural biotechnology research in automated greenhouses. He completed his Masters of Science in Electrical Engineering at the University of Rochester, and holds a Bachelors of Science in Physics with a minor in Mathematics from the State University of New York at Albany.

Dr. Thompson leads all phases of product development for consumable microfluidic and array products, including expanding functionality of both fluidic subsystems and new materials and chemistries. He received his post-doctoral training and obtained a Ph.D. in Chemistry from the University of Virginia where he performed research in the field of microfluidics under Dr. James Landers.  Dr. Thompson also holds a Master’s degree in Analytical Chemistry from Furman University and a Bachelor of Science degree in Chemistry from The College of William and Mary.

Mr. Rubin is responsible for customer technical and field support for the Company’s automated platforms including installation, integration, and onsite troubleshooting. He previously worked as an Electrical Engineer doing product design, troubleshooting, and product support for Ultra Electronics – Ocean Systems. Mr. Rubin received a Bachelor of Science in Biomedical Engineering from the University of South Carolina Columbia.

Mr. McClellan contributes to the design and development of both new and existing software products. His emphasis is primarily in the areas of graphical user interfaces, image processing, mathematical computations and machine control. Mr. McClellan has a Bachelor of Science in Computer Science from North Carolina State University.

Mr. Boone contributes to the design, research, and development of both existing and new software products including integrated computational and imaging hardware to the software development and bioinformatics for the CellRaft systems. This includes GUI programming, development and testing of image processing algorithms, machine control, and systems integration. He has a background in molecular biology with an emphasis on confocal imaging, image processing, and data analysis. He has worked at Duke University and graduated with a Bachelor of Science in Molecular Biology from Grove City College.

Ms. Wilcox contributes to developing and manufacturing all consumable array products. She previously worked in quality control and chemical analysis with Arclin Inc. and UDM Systems LLC. She received a B.S. in biological sciences from North Carolina State University with a focus in human anatomy and physiology.

Mr. Fleming’s responsibilities include commercial manufacturing, product development, and design of the Company’s manual and automated platforms. He has previous experience in machine design at Denso. Mr. Fleming earned a Bachelor of Science in Mechanical Engineering from North Carolina State University.

Ms. Watson works on the research, design, and development of both commercial and R&D systems at Cell Microsystems. She has previous professional experience as a senior engineering intern at X2 Health, LLC and robotics instructor at Stanford University. Ms. Watson earned a Bachelor of Science in Biomedical Engineering from the University of North Carolina at Chapel Hill.

Dr. Stern is focused on developing novel cellular and genomics workflows for product applications using the CellRaft Technology. She has experience in both academic and industry research settings, with a strong background in comparative physiology and the development of 2D and 3D cell-based assays for toxicological studies. Dr. Stern received a Ph.D. and Master of Science in Physiology from North Carolina State University and holds a Bachelor of Science in Animal Science from North Carolina State University.

Ms. Whitworth is responsible for validating and optimizing customer workflows on the AIR System as well as performing research to advance various R&D studies. She brings professional research experience from both academia and pharma and most recently worked as a research associate on the translational medicine team of a clinical stage oncology company. She holds a bachelor’s degree in biological sciences from the University of Alabama Huntsville.

Ms. Waters supports the team at Cell Microsystems by providing assistance in multiple areas including administrative, accounting, and logistics support. Ms. Waters received her Bachelors of Science in Managerial Accounting from the Poole College of Management at North Carolina State University.